Alopecia areata

First-Line therapies
Second-Line therapies
Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
Roseborough I, Lee H, Chwalek J, Stamper RL, Price VH. J Am Acad Dermatol 2009; 60: 705–6.
A controlled trial of 16 weeks duration with 11 patients did not confirm any response.
Another small trial of similar design has also shown the same negative result.
Third-Line therapies